NCT05520528Active, not recruiting
Impact of Group Participation on Adults With Aphasia
Source: ClinicalTrials.gov · Last updated 1 Jul 2026
Brief summary (registry, in English)
The purpose of the study is to examine the impact of group participation on adults with aphasia. Participants will complete a standard pre-and post-assessment of language abilities (speech, comprehension, reading, and/or writing). Then participants will attend 90-minute weekly reading group sessions during an academic semester.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- First submitted
- 19 Aug 2022
- Start date
- 6 Sept 2022
- Primary completion date
- 31 Jul 2028
- Lead sponsor
- University of Arkansas
- Diseases
- Stroke
- NCT number
- NCT05520528
What you commit to
- Study type: Interventional
- Planned participants: 40
- From 6 Sept 2022 to the primary completion date, 31 Jul 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- No history of childhood speech or language difficulties
- No history of major psychiatric illness, cognitive impairment, or neurological disorders such as seizures
Who the study is looking for
- Age 18 years or older
- Pre-morbid proficient speaker of English
- Diagnosis of adult-onset aphasia
- Vision and hearing sufficient to complete assessments
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| UAMS CHP Speech & Hearing Clinic Coordinator of this site? Confirm its status | Little Rock | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.